
Dalriada Drug Discovery
Mississauga, ON, Canada dalriadatx.com From their website, Nov 2026
Work here? Claim this listing
About
Dalriada Drug Discovery is a CRO focused on turnkey small molecule drug discovery from concept to preclinical development candidate. It serves global biotechnology and pharmaceutical companies from Ontario, Canada, with integrated discovery teams working under one roof.
Services
Concept to PDC Discovery Programs
Integrated drug discovery programs from concept through preclinical development candidate selection.
Target Validation
Validates biological targets to support discovery program start-up and prioritization.
Hit Identification
Finds initial active compounds for drug discovery programs.
Hit to Lead
Advances hit compounds into lead series.
Lead Optimization
Optimizes lead compounds for improved properties and activity.
Covalent Programs
Supports discovery programs centered on covalent chemistry approaches.
Degrader programs
Supports programs focused on degrader molecules.
Cannabinoid Programs
Provides discovery support for cannabinoid-related programs.
11 more services
- Psychedelic Programs
- NCE IP Creation and Expansion
- Program Design & Execution
- Program Management
- Sub-Contracting Management
- Medicinal Chemistry
- Synthetic Chemistry
- Analytical Chemistry
- In Vitro Biology
- Cell and Molecular Biology
- Protein Production
- Lead time
- Two-Week Cycle
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Recombinant protein
- ADME
- In vivo
- Offers
- Custom synthesis
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CRO
- Founded
- 2017
Locations
- Address
- 2820 Argentia Rd Unit 8-9, Mississauga, ON L5N 8G4
- Sites
- Ontario, Canada
- Serves
- Global
Contacts
- General enquiry
- info@dalriadatx.com on their site